On February 3, 2026, Onconetix Inc. held a special meeting of stockholders. Stockholders approved an amendment to the company’s Amended and Restated Certificate of Incorporation authorizing a reverse stock split of common stock at a ratio ranging from 1-for-2 to 1-for-50, with the specific ratio to be determined by the Board of Directors. Stockholders also approved the proposal to adjourn the meeting if necessary to solicit additional proxies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013724), on February 09, 2026, and is solely responsible for the information contained therein.